Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma.
about
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanomaMitochondrial electron transport is the cellular target of the oncology drug elesclomolMitochondrial respiration--an important therapeutic target in melanomaAutophagy: In the cROSshairs of cancer.4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells.Novel targeted therapies for the treatment of metastatic melanoma.Investigational cancer drugs targeting cell metabolism in clinical development.The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.Cost and economic burden of adverse events associated with metastatic melanoma treatments in five countries.Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy.Clawing back: broadening the notion of metal chelators in medicinePancreatic resection for metastatic melanoma. Case report and review of the literature.Systemic therapy of non-resectable metastatic melanoma.What is the role of chemotherapy in the treatment of melanoma?Targeting copper in cancer therapy: 'Copper That Cancer'.Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells.Investigation of the cytotoxic implications of metal chelators against melanoma and approaches to improve the cytotoxicity profiles of metal coordinating agents.Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations.Silencing of NAC1 Expression Induces Cancer Cells Oxidative Stress in Hypoxia and Potentiates the Therapeutic Activity of Elesclomol.The role of chemotherapy in the modern management of melanoma
P2860
Q26996629-118DF709-F017-42E1-89B5-B74D17249A9EQ28478835-9BBB5924-5433-4FF8-A69F-6459B2A3CFCCQ28482377-8E3DE923-0F6B-4E2F-9B02-2E91DD084B1FQ34543548-82C703D6-AA4E-470F-B782-C96441E501A9Q34884279-684D3F3A-C42F-4455-9B00-AAE8DE07233AQ34986178-89A985CE-6A0A-45FA-8A2C-1D6307C2ADADQ35615701-8F258238-6EAB-457D-B8A8-CDF1CB1BCA46Q35889790-7CBFFD29-F36A-49EC-8BBB-0A5C404E8C30Q36001592-CFC2EF22-6F63-4EF5-AD54-E0A78EF764F8Q36535726-A4187452-4C29-412F-93AC-D4D682DD25CEQ36791445-0DECD6F7-6D5D-4DEF-8EB6-07C144AC2F0EQ37762752-68AC666F-0ADB-40BE-9B34-6A7A5D129E2BQ38166572-71664249-EFA6-4A2F-A483-6293D755664AQ38193716-F72E28EE-A658-490E-9C58-89E09DC61501Q38575035-0EA87150-80B7-41CB-AFC8-A9EABEC66F3FQ38645501-08C1D57A-539A-418A-AB9E-04DAADE333FEQ38747870-8CE01783-00AA-4F4A-8E44-1ABF0DE62A41Q38759275-3B805BEB-D0A0-4C89-B90A-504A35F66C7AQ38934404-BE55EAAF-089B-4E6C-8BF0-72D5CBCCF3CAQ46256712-E95034AE-59EB-42AC-AD69-6B2AC9FA63A5Q57569574-594A1432-A3B6-4249-9857-FC6237DC3499
P2860
Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Phase II, randomized, controll ...... stage IV metastatic melanoma.
@en
Phase II, randomized, controll ...... stage IV metastatic melanoma.
@nl
type
label
Phase II, randomized, controll ...... stage IV metastatic melanoma.
@en
Phase II, randomized, controll ...... stage IV metastatic melanoma.
@nl
prefLabel
Phase II, randomized, controll ...... stage IV metastatic melanoma.
@en
Phase II, randomized, controll ...... stage IV metastatic melanoma.
@nl
P2093
P356
P1476
Phase II, randomized, controll ...... stage IV metastatic melanoma.
@en
P2093
Anthony Williams
Clay Anderson
David Lawson
Eric Jacobson
Jonathan Haddad
Laura Hutchins
Rene Gonzalez
Robert Weber
Steven Kong
Steven O'Day
P304
P356
10.1200/JCO.2008.17.1579
P407
P577
2009-10-13T00:00:00Z